Öz
Aim: Non-invasive methods applied to address cosmetic and functional problems of the genital area in female patients have been increasing in recent years. Fractional CO2 laser is used to stimulate vaginal tissue regeneration and improve vaginal elasticity. The aim of this study is to determine the demographic characteristics of female patients seeking genital rejuvenation procedures, assess patient satisfaction after the treatment, and evaluate the factors affecting patient satisfaction..
Materials and Methods: In our study conducted at the Obstetrics and Gynecology Department of Gümrük Hospital between October 2023 and August 2024, data of female patients who underwent fractional CO2 laser vaginal rejuvenation were recorded retrospectively. The study investigated the indications for laser treatment, age, parity, laser application duration, number of sessions, patient- specific treatment dosage, and post-treatment complications. Only women with negative PAP smear and HPV test results were included in the study.
Women who were receiving treatment or had undergone surgery due to genital cancer were excluded. The Pixel CO2 fractional Alma Femilift laser device was used for the procedure.
Results: A total of 14 patients presented to our clinic due to vaginal laxity. Of these, 8 (57.14%) were between 25-35 years old, 5 (35.72%) were between 35-45 years old, and 1 (7.14%) was over 45 years old and in the perimenopausal period. The Femilift laser application was performed with 2 sessions in 4 patients (28.6%) and with 1 session in 10 patients (71.4%). Post-treatment, 82.86% (n=13) of the patients reported a noticeable and significant increase in sexual satisfaction. Only 1 (7.14%) patient did not achieve satisfactory results.
Conclusion: Fractional CO2 laser vaginal tightening procedures are non-surgical, low-risk treatments that do not require anesthesia, are painless, and utilize advanced technology. As a result, significant improvements have been observed in women seeking genital rejuvenation, particularly during the premenopausal period. It has been noted that factors such as the number of pregnancies, types of deliveries, and childbirth methods influence treatment satisfaction.
Anahtar Kelimeler
Kaynakça
- Barbara, G., Facchin, F., Buggio, L., Alberico, D., Frattaruolo, M. P., & Kustermann, A. (2017). Vaginal rejuvenation: current perspectives. International journal of women's health, 513-519.
- Gold M, Andriessen A, Bader A, Alinsod R, French ES, Guerette N, Kolodchenko Y, Krychman M, Murrman S, Samuels S. Review and clinical experience exploring evidence, clinical efficacy, and safety regarding nonsurgical treatment of feminine rejuvenation. Journal of Cosmetic Dermatology 2018; 17: 289-97.
- Hashim, P. W., Nia, J. K., Zade, J., Farberg, A. S., & Goldenberg, G. (2018). Noninvasive vaginal rejuvenation. Cutis, 102(4), 243-246.
- Singh, A., Swift, S., Khullar, V., & Digesu, G. A. (2015). Laser vaginal rejuvenation: not ready for prime time. International Urogynecology Journal, 26, 163-164.
- Karcher, C., & Sadick, N. (2016). Vaginal rejuvenation using energy-based devices. International journal of women's dermatology, 2(3), 85-88.
- Salvatore S, Nappi RE, Zerbinati N, Calligaro A, Ferrero S, Origoni M. & Leone Roberti Maggiore U. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric 2014;17: 363-9.
- Adabi K, Golshahi F, Niroomansh S, Razzaghi Z, Ghaemi M. Effect of the fractional CO2 laser on the quality of life, general health, and genitourinary symptoms in postmenopausal women with vaginal atrophy: a prospective cohort. Journal of lasers in medical sciences 2020; 11: 65.
- Franic D, Fistonic I. Laser therapy in the treatment of female urinary incontinence and genitourinary syndrome of menopause: an update. Biomed Res Int 2019; 2019:1576359.
- Emerson C, Pieralli A, Bianchi C, Longinotti M, Corioni S, Auzzi N, Becorpi A, Fallani MG, Cariti G, Petraglia F. Long-term reliability of fractioned CO2 laser as a treatment for vulvovaginal atrophy (VVA) symptoms. Archives of gynecology and obstetrics, 2017; 296: 973-8.
- Lauterbach R, Dabaja H, Matanes E, Gruenwald I, Lowenstein L. The efficacy and safety of CO2 laser treatment for sexual function and vaginal laxity improvement in pre-menopausal women. Lasers in Surgery and Medicine, 2021; 53: 199-203.
- Toplu G, Serin M, Unveren T, Altinel D. Patient reported vaginal laxity, sexual function and stress incontinence improvement following vaginal rejuvenation with fractional carbon dioxide laser. J Plast Surg Hand Surg. 2021; 55:25-31.
- Gaspar A, Addamo G, Brandi H. Vaginal Fractional CO 2 Laser: A Minimally Invasive Option for Vaginal Rejuvenation. Am J Cosmet Surg 2011; 28: 156-162.
- Shobeiri SA, Kerkhof MH, Minassian VA, Bazi T. IUGA Research and Development Committee. IUGA committee opinion: laserbased vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity. Int Urogynecol J 2019; 30: 371–6.
- Cesar Arroyo. Fractional CO2 laser treatment for vulvovaginal atrophy simptoms and vaginal rejuvenation in perimenopausal women / Int J Womens Health. 2017
Öz
Amaç: Fraksiyonel CO2 lazer, vajinal doku yenilenmesini teşvik etmek ve vajinal elastikiyeti iyileştirmek için kullanılır. Bu araştırmada amaç genital rejuvenasyon işlemi isteyen kadın hastaların demografik özelliklerini belirlemek, yapılan tedavi sonrası hasta memnuniyetini ve hasta memnuniyetine etki eden faktörleri değerlendirmektir.
Gereç ve Yöntem: Merkezi Gümrük Hospitalı, Kadın hastalıkarı ve Doğum bölümünde yaptığımız araştırmada Ekim 2023 ile Ağustos 2024 tarihleri arasında fraksiyonel CO2 lazer vajinal rejuvenasyon uygulanan kadın hastaların verileri retrospektif olarak kaydedildi. Yapılan çalışmada hastaların lazer tedavi endikasyonu, yaş, parite, lazer uygulama süresi ve seans sayı, hastaya özel tedavi dozu, tedavi sonrası komplikasyonlar araştırılmıştır. PAP smear ve HPV testleri neqativ sonuç alınan kadınlar çalışmaya dahil edilmiştir. Genital kanser nedeni ile tedavi alan ve operasyon geçiren kadınlar çalışma dışı bırakılmıştır. Lazer cihazı olarak Pixel CO2 fraksiyonel Alma Femilift lazer kullanılmıştır.
Bulgular: Vajinal genişlik nedeniyle kliniğimize müracaat eden toplam 14 hastanın 8-i (%57.14) 25-35 yaş, 5-i (%35.72) 35-45 yaş, 1-i (%7.14) ise 45 yaş üzerinde ve premenopozal dönemde idi. Femilift lazer uygulaması 4 hastada (%28.6) 2 seans, 10 kadında ise (%71.4) 1 seans olarak yapılmıştır. Uygulama sonrası hastaların % 82.86 (n=13) hissedilir ve yüksek oranda cinsel tatminde artış bildirmişlerdi. Yalnız 1 (%7.14) hastada yeterli sonuç alınamamıştır.
Sonuç: Fraksiyonal CO2 lazerle vajina daraltma uygulamaları cerrahi bir işlem olmadığı için riskleri son derece az olan, anesteziye ihtiyaç duyulmadan, ağrı olmadan ve ileri teknolojili işlemlerdir. Sonuç itibarile, genital rejuvenasyon amacıyla başvuran kadın hastaların özellikle premenopoz döneminde tedaviden belirgin iyileşme görülmüş, gebelik, doğum sayısı ve doğum şeklinin tedavi memnuniyyetini etkileyen faktörler oldukları izlenilmiştir.
Anahtar Kelimeler
Kaynakça
- Barbara, G., Facchin, F., Buggio, L., Alberico, D., Frattaruolo, M. P., & Kustermann, A. (2017). Vaginal rejuvenation: current perspectives. International journal of women's health, 513-519.
- Gold M, Andriessen A, Bader A, Alinsod R, French ES, Guerette N, Kolodchenko Y, Krychman M, Murrman S, Samuels S. Review and clinical experience exploring evidence, clinical efficacy, and safety regarding nonsurgical treatment of feminine rejuvenation. Journal of Cosmetic Dermatology 2018; 17: 289-97.
- Hashim, P. W., Nia, J. K., Zade, J., Farberg, A. S., & Goldenberg, G. (2018). Noninvasive vaginal rejuvenation. Cutis, 102(4), 243-246.
- Singh, A., Swift, S., Khullar, V., & Digesu, G. A. (2015). Laser vaginal rejuvenation: not ready for prime time. International Urogynecology Journal, 26, 163-164.
- Karcher, C., & Sadick, N. (2016). Vaginal rejuvenation using energy-based devices. International journal of women's dermatology, 2(3), 85-88.
- Salvatore S, Nappi RE, Zerbinati N, Calligaro A, Ferrero S, Origoni M. & Leone Roberti Maggiore U. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric 2014;17: 363-9.
- Adabi K, Golshahi F, Niroomansh S, Razzaghi Z, Ghaemi M. Effect of the fractional CO2 laser on the quality of life, general health, and genitourinary symptoms in postmenopausal women with vaginal atrophy: a prospective cohort. Journal of lasers in medical sciences 2020; 11: 65.
- Franic D, Fistonic I. Laser therapy in the treatment of female urinary incontinence and genitourinary syndrome of menopause: an update. Biomed Res Int 2019; 2019:1576359.
- Emerson C, Pieralli A, Bianchi C, Longinotti M, Corioni S, Auzzi N, Becorpi A, Fallani MG, Cariti G, Petraglia F. Long-term reliability of fractioned CO2 laser as a treatment for vulvovaginal atrophy (VVA) symptoms. Archives of gynecology and obstetrics, 2017; 296: 973-8.
- Lauterbach R, Dabaja H, Matanes E, Gruenwald I, Lowenstein L. The efficacy and safety of CO2 laser treatment for sexual function and vaginal laxity improvement in pre-menopausal women. Lasers in Surgery and Medicine, 2021; 53: 199-203.
- Toplu G, Serin M, Unveren T, Altinel D. Patient reported vaginal laxity, sexual function and stress incontinence improvement following vaginal rejuvenation with fractional carbon dioxide laser. J Plast Surg Hand Surg. 2021; 55:25-31.
- Gaspar A, Addamo G, Brandi H. Vaginal Fractional CO 2 Laser: A Minimally Invasive Option for Vaginal Rejuvenation. Am J Cosmet Surg 2011; 28: 156-162.
- Shobeiri SA, Kerkhof MH, Minassian VA, Bazi T. IUGA Research and Development Committee. IUGA committee opinion: laserbased vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity. Int Urogynecol J 2019; 30: 371–6.
- Cesar Arroyo. Fractional CO2 laser treatment for vulvovaginal atrophy simptoms and vaginal rejuvenation in perimenopausal women / Int J Womens Health. 2017
Ayrıntılar
| Birincil Dil | Türkçe |
|---|---|
| Konular | Kadın Hastalıkları ve Doğum |
| Bölüm | Araştırma Makaleleri |
| Yazarlar | |
| Yayımlanma Tarihi | 25 Ağustos 2025 |
| Gönderilme Tarihi | 12 Mart 2025 |
| Kabul Tarihi | 6 Ağustos 2025 |
| Yayımlandığı Sayı | Yıl 2025Cilt: 64 Sayı: Özel Sayı: 1 (11. Ulusal Ürojinekoloji Kongresi Bildiri Kitapçığı) |
